Literature DB >> 33184170

MIS-C and Cardiac Conduction Abnormalities.

Nak Hyun Choi1, Michael Fremed1, Thomas Starc1, Rachel Weller1, Eva Cheung1, Anne Ferris1, Eric S Silver1, Leonardo Liberman2.   

Abstract

OBJECTIVES: Multisystem inflammatory syndrome in children (MIS-C) has spread through the pediatric population during the coronavirus disease 2019 pandemic. Our objective for the study was to report the prevalence of conduction anomalies in MIS-C and identify predictive factors for the conduction abnormalities.
METHODS: We performed a single-center retrospective cohort study of pediatric patients <21 years of age presenting with MIS-C over a 1-month period. We collected clinical outcomes, laboratory findings, and diagnostic studies, including serial electrocardiograms, in all patients with MIS-C to identify those with first-degree atrioventricular block (AVB) during the acute phase and assess for predictive factors.
RESULTS: Thirty-two patients met inclusion criteria. Median age at admission was 9 years. Six of 32 patients (19%) were found to have first-degree AVB, with a median longest PR interval of 225 milliseconds (interquartile range 200-302), compared with 140 milliseconds (interquartile range 80-178) in patients without first-degree AVB. The onset of AVB occurred at a median of 8 days after the initial symptoms and returned to normal 3 days thereafter. No patients developed advanced AVB, although 1 patient developed a PR interval >300 milliseconds. Another patient developed new-onset right bundle branch block, which resolved during hospitalization. Cardiac enzymes, inflammatory markers, and cardiac function were not associated with AVB development.
CONCLUSIONS: In our population, there is a 19% prevalence of first-degree AVB in patients with MIS-C. All patients with a prolonged PR interval recovered without progression to high-degree AVB. Patients admitted with MIS-C require close electrocardiogram monitoring during the acute phase.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2020        PMID: 33184170     DOI: 10.1542/peds.2020-009738

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Recent research on the application of biologics in the treatment of multisystem inflammatory syndrome in children after SARS-CoV-2 infection.

Authors:  Han-Yu Cui; Chang-Ping Hu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-02-15

Review 2.  Return to Activity After SARS-CoV-2 Infection: Cardiac Clearance for Children and Adolescents.

Authors:  Devyani Chowdhury; Michael A Fremed; Peter Dean; Julie S Glickstein; Jeff Robinson; Neil Rellosa; Deepika Thacker; David Soma; Susannah M Briskin; Chad Asplund; Jonathan Johnson; Christopher Snyder
Journal:  Sports Health       Date:  2021-08-24       Impact factor: 4.355

Review 3.  MIS-C related to SARS-CoV-2 infection: a narrative review of presentation, differential diagnosis, and management.

Authors:  Salika Gadiwala; Ayushi Mistry; Sejal Patel; Avanthika Chaithanya; Stuti Pathak; Travis Satnarine; Daria Bekina-Sreenivasan; Abdul Akim Bakarr; Bibhuti Bhusan Das; Raja Chandra Chakinala; Saurabhkumar Patel; Sathya Areti
Journal:  Infez Med       Date:  2022-09-01

4.  Bradycardia associated with Multisystem Inflammatory Syndrome in Children with COVID-19: a case series.

Authors:  Gian Paolo Ciccarelli; Eugenia Bruzzese; Gaetano Asile; Edoardo Vassallo; Luca Pierri; Vittoria De Lucia; Alfredo Guarino; Andrea Lo Vecchio
Journal:  Eur Heart J Case Rep       Date:  2021-10-14

Review 5.  Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19.

Authors:  Eveline Y Wu; M Jay Campbell
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

Review 6.  Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?

Authors:  Daniel D Reiff; Randy Q Cron
Journal:  Curr Rheumatol Rep       Date:  2022-02-12       Impact factor: 4.686

Review 7.  Longitudinal Outcomes and Monitoring of Patients With Multisystem Inflammatory Syndrome in Children.

Authors:  Michael A Fremed; Kanwal M Farooqi
Journal:  Front Pediatr       Date:  2022-04-01       Impact factor: 3.418

8.  Cardiac Screening: An Important Diagnostic Tool in the Early Identification of High-Risk Children with Post-COVID-19 Multisystem Inflammatory Syndrome in Children.

Authors:  Rameesha Shafqat; Kubra Fatima; Anisa Begum; Shafqat Qamer
Journal:  Malays J Med Sci       Date:  2022-06-28

9.  Does Multisystem Inflammatory Syndrome Only Mimic Acute Appendicitis in Children or Can It Coexist: When Should We Suspect MIS-C?

Authors:  Idilė Vansevičienė; Ugnė Krunkaitytė; Inga Dekerytė; Mindaugas Beržanskis; Aušra Lukošiūtė-Urbonienė; Dalius Malcius; Vidmantas Barauskas
Journal:  Medicina (Kaunas)       Date:  2022-08-14       Impact factor: 2.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.